Exacerbations Down in Asthma Patients on GLP-1R Agonists for T2D
MONDAY, June 14, 2021 -- For adults with type 2 diabetes and asthma, exacerbation rates are lower for those prescribed glucagon-like peptide-1 receptor (GLP-1R) agonists, according to a study recently published in the American Journal of Respiratory...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Asthma | Diabetes | Diabetes Type 2 | Endocrinology | Pharmaceuticals | Respiratory Medicine | Study